Trials / Terminated
TerminatedNCT01612884
Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 67 (actual)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Personalized treatment approaches and antiplatelet drug choice have been proposed to optimize safety of coronary stenting by reducing heart attacks and repeat interventions while simultaneously minimizing adverse bleeding events. This study compares the efficacy of two laboratory guided treatment algorithms to personalize antiplatelet medication choice after coronary stenting
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prasugrel | Prasugrel 60mg loading dose at time of PCI if clopidogrel non-responder |
| DRUG | Clopidogrel | Clopidogrel 300mg loading dose at time of PCI if clopidogrel responder |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2017-03-01
- Completion
- 2017-03-01
- First posted
- 2012-06-06
- Last updated
- 2018-04-26
- Results posted
- 2018-04-26
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01612884. Inclusion in this directory is not an endorsement.